Most life sciences marketing teams don't yet understand that ranking well in Google no longer guarantees that AI systems will cite you. Research from GEO tracking firm Brandlight found that the overlap between top Google search results and AI-cited sources has dropped from 70% to below 20% (1). That gap is growing, and it has significant implications for how you think about your content program.

For years, the logic of content marketing in life sciences was straightforward. Produce well-optimized content, earn rankings, get traffic. That logic still holds for traditional search. But when a clinical researcher asks Perplexity which CRO platforms have the strongest regulatory submission track record, or when a procurement manager asks ChatGPT to compare genomics instrument vendors, the results they get are not drawn from the same pool as Google's page one. AI systems have their own preferences for which sources to cite; and those preferences can be understood and optimized for.

This is the discipline of Generative Engine Optimization, or GEO. And for life sciences companies that depend on credibility and authority to win complex, high-stakes deals, it may be the most important content investment you can make in the next twelve months.

How AI Systems Actually Choose What to Cite

Understanding GEO starts with understanding how AI answer engines make citation decisions. The process is not algorithmic in the same way traditional search ranking is. AI models are trained on large bodies of text and learn, through that training, which sources tend to provide specific, accurate, well-structured, and authoritative answers to questions. When a user submits a query, the model retrieves and synthesizes content from sources that its training has associated with credibility on that topic.

Several factors consistently influence citation likelihood across platforms. Specificity matters more than comprehensiveness. AI models are good at synthesizing general information — they don't need your content to restate what's already widely known. What they do cite are sources that add something specific: a data point, a named methodology, a concrete outcome, a technical mechanism that the model can't easily derive from its general training. A white paper on organoid culture automation that includes validated throughput numbers from a specific application is far more citable than one that explains what organoid automation is.

Structure is the second major factor. Content that answers questions directly, with clear headings and logical organization, is significantly more likely to be extracted as a citation. The first 200 words of any article or page should answer the primary question directly, not build toward it. This mirrors the TLDR (too long, didn't read)-first structure that top-performing GEO content uses consistently, and it differs meaningfully from the inverted-pyramid approach many marketers were trained on.

Author credibility and third-party validation are the third factor. AI systems learn to weight sources that other credible sources reference. Brand mentions correlate three times more strongly with AI visibility than backlinks alone. A medical device company whose white papers are cited in industry publications, referenced in conference presentations, or mentioned in analyst reports becomes a progressively more reliable citation source across AI platforms. This is the GEO equivalent of link building. But the currency is earned mentions rather than hyperlinks.

Platform Differences Worth Knowing

Not all AI platforms behave the same way, and a nuanced GEO strategy accounts for those differences.

Perplexity is heavily citation-focused and uses real-time web retrieval. It pulls from recent, up-to-date content and is more transparent about its sources than other platforms. For life sciences companies, this means fresh content (updated protocol guides, recent application notes, current regulatory commentary) performs particularly well on Perplexity. It also means content freshness is a genuine ranking factor, not just an SEO best practice.

Google's Gemini integrates deeply with Google's existing search infrastructure. Strong Google SEO performance translates into Gemini visibility more directly than into other platforms. Companies that have invested in technical SEO, structured data, and E-E-A-T signals will find their Gemini presence is already better established than their ChatGPT or Perplexity presence.

ChatGPT has over 700 million weekly active users and draws heavily from its training data, supplemented by web retrieval when web browsing is enabled. It favors well-structured, logical content and tends to synthesize information across sources rather than quoting directly. Authority in ChatGPT is built over time through consistent publishing, earned mentions, and topical depth...not through any single piece of content.

Claude tends to favor content that is well-organized and logically argued, with a preference for sources that provide clear reasoning rather than just assertions. For life sciences companies, this rewards content that explains the 'why' behind technical claims rather than simply stating conclusions.

Practical GEO Tactics for Life Sciences Companies

The research is clear on which tactics move the needle most. Adding statistics to content improves AI visibility by approximately 40% (2). Distributing content to a wide range of publications increases AI citations by up to 325% compared to self-published-only strategies (3). These are significant multipliers, and both are actionable.

Start with an answer-first content architecture. For every key page on your site, identify the primary question it answers and make sure that question is answered directly in the first paragraph. Not teased, not built toward...answered. This applies to product pages, application notes, blog posts, and FAQs. The FAQ format in particular is one of the most reliably citable content types across all AI platforms, because it maps directly to the question-and-answer structure that AI systems use when generating responses.

Develop original data assets. Among all GEO tactics, original research and proprietary data are the highest-value investments. A pharma company that publishes its own benchmark data on clinical trial timeline variability, or a lab automation company that publishes throughput comparisons across assay formats, creates content that AI systems cannot synthesize from general knowledge. These assets compound over time as they accumulate citations from other sources.

Build a deliberate earned-mention strategy. Identify the publications, platforms, and voices in your space that AI models are most likely to draw from. Peer-reviewed journals, recognized industry publications, analyst reports, and major conference proceedings all carry high citation weight. Contributing articles, presenting at conferences, and securing analyst coverage are not just brand-awareness plays in the GEO era; they are direct investments in AI citation authority.

Implement structured data consistently. Schema markup (particularly FAQ schema, article schema, and organization schema) helps AI systems understand and categorize your content. This is a technical investment, but it has measurable impact on how reliably your content is retrieved and cited across platforms.

Track prompt volume, not just keyword volume. The discipline of GEO introduces a new demand signal: how often people are asking AI systems about your topic or category. Tools like Semrush now track this. Understanding which questions your buyers are putting to AI systems is the starting point for knowing what content to create.

The Measurement Shift

Traditional content metrics — traffic, rankings, time on page — don't capture GEO performance. The integrated measurement approach that leading teams are using in 2026 combines citation tracking (how often each AI platform cites or names your brand for priority prompts), share of AI answers over time, and referral traffic from AI platforms.

Running your own citation audit is the most practical starting point. Open ChatGPT, Perplexity, Claude, and Gemini. Ask the questions your buyers are most likely to ask. Note who gets cited and why. The pattern across those results is your GEO gap analysis, and it's more actionable than any keyword report.

The Underlying Point

GEO is not a replacement for SEO. It's an expansion of the playing field. For life sciences companies, the fundamentals that make content genuinely excellent are the same across both disciplines: specificity, credibility, authority, and consistent publishing. What changes is the measurement framework and the distribution strategy.

The companies that invest in GEO now are building citation authority that compounds over time, in exactly the way domain authority did in the early years of SEO. The window to establish early advantage is open. Most competitors in the life sciences space haven't started yet.

Up next: How to build an account-based marketing program that aligns demand generation with sales in a long-cycle B2B world — and why the buying committee expansion makes ABM more relevant than ever.

I work with life sciences companies on digital marketing strategy, from SEO/AEO and content to demand generation, positioning and messaging, omnichannel campaigns, product launches, voice of customer, and more. If this resonated, or if you have a different perspective, I'd genuinely like to hear from you.